Table 3. Sensitivity Enhancement Ratios and Dose Enhancement Factors calculated for skin cells.
| Cell line (AuNP) | SER4Gy 6 MV |
SER4Gy 220 kV |
DEF0.3 6 MV Dose 0/ Dose NP |
DEF0.3 220 kV Dose 0/ Dose NP |
|---|---|---|---|---|
| HSC-3 (50:50) | 1.40 | 1.73 | 6.59/5.98 = 1.10 | 5.46/3.60 = 1.52 |
| HSC-3 (0:100) | 1.02 | 1.63 | 6.59/6.73 = 0.98 | 4.52/3.89 = 1.16 |
| HSC-3 (citrate) | N/D | 0.97 | N/D | 4.52/4.39 = 1.03 |
| HaCaT (50:50) | 1.10 | 1.08 | 4.97/4.22 = 1.18 | 5.61/4.02 = 1.40 |
| HaCaT (0:100) | 0.91 | 0.99 | 4.97/5.01 = 0.99 | 5.02/5.08 = 0.99 |
| HaCaT (citrate) | N/D | 0.93 | N/D | 5.02/4.95 = 1.01 |